CLINICAL_TRIALS
trial_result
· 2009-03-27
Clinical Trial Update: Gemcitabine in Ovarian Cancer [Phase 2]
Summary
A Phase 2 clinical trial of gemcitabine for ovarian cancer has completed, with results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-03-27